FDA Okays Subcutaneous Ocrelizumab for MS
The US Food and Drug Administration (FDA) has approved a subcutaneous formulation of the anti-CD2src antibody ocrelizumab (Ocrevus Zunovo, Genentech)...
The US Food and Drug Administration (FDA) has approved a subcutaneous formulation of the anti-CD2src antibody ocrelizumab (Ocrevus Zunovo, Genentech)...
Key findings from the National Poll on Healthy Aging about the reasons for using cannabis cited by people age 50...